StockUnited StatesNasdaqGS

RPRX

Royalty Pharma plc

Healthcare · Biotechnology

63.86USD

+0.1100 (+0.17%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Valuation

P/E (TTM)

45.28x

P/E (Forward)

10.99x

EV/EBITDA

26.05x

EV/Revenue

15.58x

P/S (TTM)

14.55x

P/B

3.77x

FCF Yield

-3.24%

Dividend Yield

1.47%

Gross Margin

95.82%

Operating Margin

59.61%

Net Margin

32.14%

Peer Comparison — Biotechnology

Company	Mkt Cap	P/E	EV/EBITDA	FCF Yield	Rev Growth	Div Yield
RPRXRoyalty Pharma plc	$36.90B	45.28x	26.05x	-3.24%	16.50%	1.47%
VRTXVertex Pharmaceuticals Incorporated	$132.71B	30.51x	24.88x	1.98%	12.50%	0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

Computing valuation metrics…